Atlas Trials

Low Dose Empagliflozin in Adults With Type 1 Diabetes on Closed Loop Insulin System

Clinical trial NCT04450563 · COMPLETED

Trial details

NCT number
NCT04450563
Sponsor
McGill University
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Type 1 Diabetes
Start date
2020-11-02
Primary completion
2022-01-05
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.